Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Dalvie

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Chemical Research in Toxicology|January 17, 2009
Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolitesDeepak Dalvie, R Scott Obach, Ping Kang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2021
Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5Julie V Selkirk, Kevin C Dines, Yingzhuo Grace Yan, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2013
Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone seriesHengmiao Cheng, Jacqui E Hoffman, Phuong T Le, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 6, 2021
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor ModulatorSekhar Surapaneni, Usha Yerramilli, April Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTORPhuong T Le, Hengmiao Cheng, Sacha Ninkovic, et al.
Drug Metabolism Reviews|May 13, 2026
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometryAlex Zelter, Guo Zhong, Michal Maes, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjectsTheodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial InfectionsNatalie Hawryluk, Dale Robinson, Yixing Shen, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PKSteven P Tanis, Michael B Plewe, Ted W Johnson, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Chemical Research in Toxicology|January 17, 2009
Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolitesDeepak Dalvie, R Scott Obach, Ping Kang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2021
Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5Julie V Selkirk, Kevin C Dines, Yingzhuo Grace Yan, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2013
Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone seriesHengmiao Cheng, Jacqui E Hoffman, Phuong T Le, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 6, 2021
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor ModulatorSekhar Surapaneni, Usha Yerramilli, April Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTORPhuong T Le, Hengmiao Cheng, Sacha Ninkovic, et al.
Drug Metabolism Reviews|May 13, 2026
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometryAlex Zelter, Guo Zhong, Michal Maes, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjectsTheodore R Johnson, Weiwei Tan, Lance Goulet, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial InfectionsNatalie Hawryluk, Dale Robinson, Yixing Shen, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PKSteven P Tanis, Michael B Plewe, Ted W Johnson, et al.
Pageof 5